GLP 3RET

Description

RET is an investigational triple-agonist peptide designed for weight loss and type 2 diabetes management.  Unlike first-generation GLP-1 and dual-agonist drugs, it targets three metabolic pathways simultaneously:

• GLP-1 Receptor: Suppresses appetite and regulates blood sugar.
• GIP Receptor: Enhances insulin secretion and optimizes fat metabolism.
• Glucagon (GCG) Receptor: Increases energy expenditure (burns more calories).